PRESS STATEMENTS

02.25.2021

Pfizer Statement on Results of Second Annual Pay Equity Study Among Colleagues Worldwide

02.19.2021

President Biden Visits Pfizer’s Kalamazoo Manufacturing Facility

02.17.2021

In Vitro Study Published in The New England Journal of Medicine Demonstrates Sera from Individuals Immunized with the Pfizer- BioNTech COVID-19 Vaccine Neutralize SARS-CoV-2 with South African Variant Spike Mutations

02.08.2021

Pfizer and BioNTech Publish Data from in Vitro Studies in "Nature Medicine" Demonstrating COVID-19 Vaccine Elicits Antibodies that Neutralize SARS-CoV-2 with Key Mutations Present in U.K. and South African Variants

02.01.2021

Pfizer and BioNTech Publish Preclinical Data from Investigational COVID-19 Vaccine Program in Nature

01.29.2021

Pfizer and BioNTech Publish Data on COVID-19 Vaccine-Induced Antibodies’ Ability to Neutralize SARS-CoV-2 U.K. Strain Pseudovirus in Cell Culture in Science

01.27.2021

In Vitro Studies Demonstrate Pfizer and BioNTech COVID-19 Vaccine Elicits Antibodies that Neutralize SARS-CoV-2 with Key Mutations Present in U.K. and South African Variants

01.26.2021

Statement on ATMI Ranking

01.20.2021

Pfizer and BioNTech Publish Results of Study Showing COVID-19 Vaccine Elicits Antibodies that Neutralize Pseudovirus Bearing the SARS-CoV-2 U.K. Strain Spike Protein in Cell Culture

01.15.2021

Statement by Pfizer Chairman and CEO Albert Bourla

01.15.2021

Statement on European Upscaling as well as Impact on Deliveries

01.08.2021

An In Vitro Study Shows Pfizer-BioNTech COVID-19 Vaccine Elicits Antibodies that Neutralize SARS-CoV-2 with a Mutation Associated with Rapid Transmission

12.17.2020

Pfizer Update on COVID-19 Vaccine Distribution

12.15.2020

Pfizer Doses First Participants as Part of Global Achondroplasia Phase 2 Development Program

12.09.2020

Statement on EMA Cyberattack

12.01.2020

Pfizer and BioNTech Submitted Application for Conditional Marketing Authorization for COVID-19 Vaccine to the EMA

11.20.2020

Pfizer Receives European Approval for Oncology Supportive Care Biosimilar, NYVEPRIA™ (pegfilgrastim)

11.16.2020

Pfizer Update On Our U.S. COVID-19 Vaccine Candidate Distribution Preparedness

11.10.2020

Pfizer Statement on Geodon (ziprasidone) Trial Closure in the United States

10.29.2020

New Report Identifies Need for More Effective Policy Responses and Investment to Prevent Strokes in Europe